Inventor · disambiguated record
Christoph Spiess
Also filed as: SPIESS CHRISTOPH
16 granted patents·17 pending applications·69 citations·filing 2011–2024
90Inventor score
Top patents by PatentIndex Score
33 records- 0195US9637557B2Production of heteromultimeric proteinsSCHEER JUSTIN·Filed 2011·Granted May 2, 2017·58 cites·75 claims
- 0287US11116840B2Multispecific antigen-binding proteinsGENENTECH INC·Filed 2017·Granted Sep 14, 2021·3 cites·16 claims
- 0386US2025011471A1Antibodies and methods of useGENENTCH INC·Filed 2024·Application pending·0 cites
- 0485US2025177523A1Multispecific antigen-binding proteinsGENENTECH INC·Filed 2024·Application pending·0 cites
- 0585US2024383984A1HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USEGENENTECH INC·Filed 2024·Application pending·0 cites
- 0684US2024026033A1Antibodies and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 0784US2025032610A1Multispecific antigen-binding proteinsGENENTECH INC·Filed 2024·Application pending·0 cites
- 0883US2023357445A1Production of heteromultimeric proteinsGENENTECH INC·Filed 2023·Application pending·0 cites
- 0979US10662254B2Hinge modified antibody fragments and methods of makingGENENTECH INC·Filed 2018·Granted May 26, 2020·2 cites·10 claims
- 1079US10323094B2Humanized and affinity matured antibodies to FcRH5 and methods of useGENENTECH INC·Filed 2016·Granted Jun 18, 2019·2 cites·24 claims
- 1178US12297270B2Bispecific antigen-binding molecules and methods of useGENENTECH INC·Filed 2023·Granted May 13, 2025·0 cites·36 claims
- 1277US12030947B2Humanized and affinity matured antibodies to FcRH5 and methods of useGENENTECH INC·Filed 2021·Granted Jul 9, 2024·0 cites·70 claims
- 1376US11555076B2Anti-MIC antibodies and methods of useGENENTECH INC·Filed 2017·Granted Jan 17, 2023·2 cites·32 claims
- 1475US11866498B2Bispecific antigen-binding molecules and methods of useGENENTECH INC·Filed 2019·Granted Jan 9, 2024·1 cites·24 claims
- 1575US9884919B2Methods of treatment with bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1GENENTECH INC·Filed 2016·Granted Feb 6, 2018·1 cites·16 claims
- 1675US2022064331A1Antibodies and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 1773US2024190966A1Anti-ly6g6d antibodies and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 1872US11192950B2Humanized and affinity matured antibodies to FcRH5 and methods of useGENENTECH INC·Filed 2019·Granted Dec 7, 2021·0 cites·38 claims
- 1972US2021171662A1Production of heteromultimeric proteinsGENENTECH INC·Filed 2020·Application pending·0 cites
- 2071US12053525B2Multispecific antigen-binding proteinsGENENTECH INC·Filed 2021·Granted Aug 6, 2024·0 cites·21 claims
- 2170US10882921B2Host cell comprising nucleic acids encoding bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 and antibody productionGENENTECH INC·Filed 2019·Granted Jan 5, 2021·0 cites·21 claims
- 2267US9873748B2Bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1GENENTECH INC·Filed 2014·Granted Jan 23, 2018·0 cites·12 claims
- 2364US10246518B2Nucleic acids encoding bispecific antibodies binding to beta-Klotho and fibroblast growth factor receptor 1GENENTECH INC·Filed 2017·Granted Apr 2, 2019·0 cites·5 claims
- 2463US2019185584A1Production of heteromultimeric proteinsGENENTECH INC·Filed 2018·Application pending·0 cites
- 2563US2024360229A1Multispecific antibodies and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 2662US11845799B2Anti-Ly6G6D antibodies and methods of useGENENTECH INC·Filed 2020·Granted Dec 19, 2023·0 cites·44 claims
- 2761US2018282431A1Production of heteromultimeric proteinsGENENTECH INC·Filed 2017·Application pending·0 cites
- 2854US2020308304A1Hinge modified antibody fragments and methods of makingGENENTECH INC·Filed 2020·Application pending·0 cites
- 2953US2022048990A1Immunoglobulin a antibodies and methods of production and useGENENTECH INC·Filed 2021·Application pending·0 cites
- 3041US11434482B2Methods of identifying bacteria comprising binding polypeptidesGENENTECH INC·Filed 2017·Granted Sep 6, 2022·0 cites·36 claims
- 3138US2019040142A1Methods of screening for multispecific antibodiesGENENTECH INC·Filed 2018·Application pending·0 cites
- 3235US2016207995A1Anti-il-4 antibodies and bispecific antibodies and uses thereofGENENTECH INC·Filed 2015·Application pending·0 cites
- 3335US2017334985A1Anti-il-13/il-17 bispecific antibodies and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christoph Spiess files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →